Free Trial
NYSEAMERICAN:OGEN

Oragenics (OGEN) Stock Price, News & Analysis

Oragenics logo
$1.36 -0.03 (-2.16%)
Closing price 10/15/2025 04:10 PM Eastern
Extended Trading
$1.36 -0.01 (-0.37%)
As of 10/15/2025 07:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Oragenics Stock (NYSEAMERICAN:OGEN)

Advanced

Key Stats

Today's Range
$1.32
$1.39
50-Day Range
$1.03
$1.42
52-Week Range
$1.01
$18.90
Volume
110,136 shs
Average Volume
247,633 shs
Market Capitalization
$5.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Oragenics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
2nd Percentile Overall Score

OGEN MarketRank™: 

Oragenics scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Oragenics.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Oragenics is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Oragenics is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    2.86% of the float of Oragenics has been sold short.
  • Short Interest Ratio / Days to Cover

    Oragenics has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oragenics has recently increased by 252.55%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Oragenics does not currently pay a dividend.

  • Dividend Growth

    Oragenics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.86% of the float of Oragenics has been sold short.
  • Short Interest Ratio / Days to Cover

    Oragenics has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oragenics has recently increased by 252.55%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    1 people have searched for OGEN on MarketBeat in the last 30 days.
  • MarketBeat Follows

    2 people have added Oragenics to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Oragenics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.90% of the stock of Oragenics is held by insiders.

  • Percentage Held by Institutions

    Only 18.71% of the stock of Oragenics is held by institutions.

  • Read more about Oragenics' insider trading history.
Receive OGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oragenics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OGEN Stock News Headlines

Nvidia CEO Makes First Ever Tesla Announcement
While headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $25 trillion AI revolution — one that Nvidia’s CEO himself has called a “multi-trillion-dollar future industry” — and he’s uncovered a little-known stock 168 times smaller than Nvidia that could be positioned to ride this breakthrough.tc pixel
Oragenics Q2 2025 Shareholder Update
See More Headlines

OGEN Stock Analysis - Frequently Asked Questions

Oragenics' stock was trading at $11.0790 on January 1st, 2025. Since then, OGEN stock has decreased by 87.7% and is now trading at $1.36.

Oragenics, Inc. (NYSEAMERICAN:OGEN) announced its earnings results on Monday, August, 16th. The company reported ($54.00) earnings per share (EPS) for the quarter, beating the consensus estimate of ($72.00) by $18.00.

Oragenics shares reverse split on the morning of Monday, January 23rd 2023.The 1-60 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of OGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oragenics investors own include Imunon (CLSN), Jaguar Animal Health (JAGX), Biocept (BIOC), OPKO Health (OPK), Sorrento Therapeutics (SRNE) and Amarin (AMRN).

Company Calendar

Last Earnings
8/16/2021
Today
10/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:OGEN
Previous Symbol
NYSE:OGEN
CIK
1174940
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($21.42)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.57 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-3,614.27%
Return on Assets
-324.80%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.50
Quick Ratio
0.50

Sales & Book Value

Annual Sales
$40 thousand
Price / Sales
140.42
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.51) per share
Price / Book
-2.67

Miscellaneous

Outstanding Shares
4,130,000
Free Float
3,925,000
Market Cap
$5.62 million
Optionable
N/A
Beta
0.83
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSEAMERICAN:OGEN) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners